Table 3.

Relationship of target miRNA on clinicopathological details.

Target miRNA	Grade		Lymph Node Status		OR Status		PR Status		HER2 Status
	2	3	+Ve	−Ve	+Ve	−Ve	+Ve	−Ve	+Ve	−Ve
Let 7a	p = 0.112		p = 0.443		p = 0.242		p = 0.545		p = 0.407
	(n = 59, n = 50)		(n = 70, n = 40)		(n = 71, n = 39)		(n = 59, n = 52)		(n = 32, n = 79)
miR-21	p = 0.124		p = 0.752		p = 0.090		p = 0.164		p = 0.783
	(n = 61, n = 49)		(n = 71, n = 40)		(n = 73, n = 39)		(n = 59, n = 53)		(n = 34, n = 78)
miR-145	p = 0.968		p = 0.075		p = 0.406		p = 0.063		p = 0.877
	(n = 60, n = 48)		(n = 71, n = 38)		(n = 71, n = 39)		(n = 58, n = 52)		(n = 32, n = 78)
miR-155	p = 0.217		p = 0.621		p = 0.483		p = 0.986		p = 0.593
	(n = 60, n = 50)		(n = 71, n = 40)		(n = 73, n = 39)		(n = 59, n = 53)		(n = 34, n = 78)
miR-195	p = 0.016		p = 0.252		p = 0.014		p = 0.580		p = 0.477
	(n = 61, n = 49)		(n = 71, n = 40)		(n = 74, n = 38)		(n = 59, n = 53)		(n = 32, n = 80)